Tim Kaine actually said...

"I think that international reference pricing might be a good fallback. It may be a good way of setting parameters."

"If you imagine how much that would be for all of the drugs that have been on the market for multiple years and have reached really high prices, then, yes, that would also translate to improved consume..."

"I've just always been struck by the fact that the U.S. does not negotiate for prescription drug pricing under Medicare Part D."

"I raised with the previous administration the notion that we pay so much more than other nations do."